Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
Share a link:
https://casecent.re/p/21443
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
This is the sixth of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes Swiss-based Novartis. During the period 1998-1999, the company conducted business through three divisions: Healthcare, Agribusiness, and Consumer Health. Novartis concentrated on the therapeutic areas of immunology and inflammatory diseases, central nervous system, hormone therapy and metabolism, cardiovascular and circulatory disorders, respiratory diseases, and dermatology. The case offers a summary of activity in these key areas. Revenue and balance sheet information is also provided. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources
About
Abstract
This is the sixth of an eight-case series (301-146-1 to 301-149-1 and 302-037-1 to 302-040-1). This case describes Swiss-based Novartis. During the period 1998-1999, the company conducted business through three divisions: Healthcare, Agribusiness, and Consumer Health. Novartis concentrated on the therapeutic areas of immunology and inflammatory diseases, central nervous system, hormone therapy and metabolism, cardiovascular and circulatory disorders, respiratory diseases, and dermatology. The case offers a summary of activity in these key areas. Revenue and balance sheet information is also provided. May be used alone or with others in the series Global Biotechnology Winners. Suitable for graduate MBA and executive level courses in strategy, corporate strategy, and strategy relating to biotechnology and pharmaceuticals.
Settings
Related
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 17 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 26 June 2001
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 16 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 14 pages
Data source: Published sources
Subject category:
Strategy and General Management
Published by:
Babson College
Version: 14 March 2002
Length: 15 pages
Data source: Published sources